recommended for detection of hDcp2 of human origin by WB, IP and ELISA
Modification Notes
The major pathway of eukaryotic mRNA decay involves deadenylation-dependent decapping followed by 5’ to 3’ exonucleolytic degradation (4). Human decapping enzyme 2 (hDcp2) is an mRNA decapping enzyme which contains intrinsic decapping activity (1,2). In nonsense-mediated decay, the human decapping complex, made up of hDcp1 and hDcp2, may be recruited to mRNAs containing premature termination codons by nonsense-mediated decay factor (Upf) proteins (2). The decapping activator complex (Lsm1p-7p) is also involved in the recruitment of the decapping complex, indicated by data showing that Lsm1p-7p enhances the coimmunoprecipitation of the complex with mRNA (4). Dcp2 specifically hydrolyzes methylated capped RNA to release m(7)GDP, thereby aiding in mRNA degradation (1). Both Dcp1 and Dcp2 colocalize in the cytoplasm, which is consistent with their role in mRNA decay (3).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPELISA
WB:1:500~1:2000 IP:1:100~1:500 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of hDcp2 of human origin by WB IP and ELISA
Tissue Specificity
recommended for detection of hDcp2 of human origin by WB, IP and ELISA